Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 2
2007 1
2009 2
2013 1
2014 2
2015 2
2016 2
2018 3
2019 3
2020 2
2021 3
2022 12
2023 4
2024 7
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial.
Huang LM, Schibler A, Huang YC, Tai A, Chi H, Chieng CH, Wang JL, Goldbart A, Tang SP, Huang YC, George S, Alabaz D, Bentur L, Su SC, de Bruyne J, Karadag B, Gu F, Zou G, Toovey S, DeVincenzo JP, Wu JZ. Huang LM, et al. Among authors: alabaz d. Influenza Other Respir Viruses. 2023 Jul 25;17(7):e13176. doi: 10.1111/irv.13176. eCollection 2023 Jul. Influenza Other Respir Viruses. 2023. PMID: 37502622 Free PMC article. Clinical Trial.
Clesrovimab for Prevention of RSV Disease in Healthy Infants.
Zar HJ, Simões EAF, Madhi SA, Ramilo O, Senders SD, Shepard JS, Laoprasopwattana K, Piedrahita J, Novoa JM, Vargas SL, Dionne M, Jackowska T, Liu E, Ishihara Y, Ikeda K, Zhang Y, Railkar RA, Lutkiewicz J, Vora KA, Zang X, Maas BM, Lee AW, Guerra A, Sinha A; CLEVER (MK-1654-004) Study Group. Zar HJ, et al. N Engl J Med. 2025 Oct 2;393(13):1292-1303. doi: 10.1056/NEJMoa2502984. Epub 2025 Sep 17. N Engl J Med. 2025. PMID: 40961446 Clinical Trial.
Congenital Toxoplasmosis and Long-term Outcomes.
Gundeslioglu OO, Haytoglu Z, Esen E, Alabaz D, Cay U, Ozlu F, Kibar F, Cetiner S. Gundeslioglu OO, et al. Among authors: alabaz d. Turkiye Parazitol Derg. 2024 Mar 5;48(1):8-14. doi: 10.4274/tpd.galenos.2024.74046. Turkiye Parazitol Derg. 2024. PMID: 38449361 Free article. English.
Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease.
Zar HJ, Bont LJ, Manzoni P, Muñoz FM, Ramilo O, Chen PY, Novoa JM, Ordoñez GA, Tsolia M, Tapiéro B, Acuña-Ávila MI, Castellanos JM, Meyer M, Morioka I, Chen Z, Railkar RA, Zang X, Maas BM, Likos A, Lee AW, Castagnini LA, Sinha A; SMART (MK-1654-007) Study Group. Zar HJ, et al. N Engl J Med. 2025 Oct 2;393(13):1343-1345. doi: 10.1056/NEJMc2506107. Epub 2025 Sep 17. N Engl J Med. 2025. PMID: 40961423 No abstract available.
Clinical experience with ceftazidime/avibactam for the treatment of extensively drug-resistant or pandrug-resistant Klebsiella pneumoniae in neonates and children.
Gundeslioglu OO, Haytoglu Z, Gumus HH, Ekinci F, Kibar F, Cay U, Alabaz D, Ozlu F, Horoz OO, Yıldızdas RD. Gundeslioglu OO, et al. Among authors: alabaz d. Eur J Clin Microbiol Infect Dis. 2024 Dec;43(12):2361-2369. doi: 10.1007/s10096-024-04948-y. Epub 2024 Oct 1. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39352616
54 results